Trial Profile
A Prospective, Single Center, Observational Study on the Predictive Factors of Ovarian Response in Ovulation Induction (OI) With Intrauterine Insemination (IUI) of a Gonal-f Low-dose Step-up Regimen
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Chorionic gonadotropin
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 27 Nov 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 13 Oct 2011 Actual end date (September 2010) added as reported by ClinicalTrials.gov.
- 13 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.